Global Exocrine Pancreatic Insufficiency Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026

  • ID:PD008948
  • February 2020
  • Value Market Research
                          

The report on the Global Exocrine Pancreatic Insufficiency Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
 
Study period considered for research of this market:

  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Till: 2026
 
A glimpse of the major drivers and restraints affecting this market is mentioned below:
Drivers
  • Increase in prevalence of diabetes
  • Rise in prevalence of cystic fibrosis and chronic pancreatitis accentuates
  • Increasing global incidences of exocrine pancreatic insufficiency
  • Demand of advanced therapeutics and presence of significant number of pipeline drugs
  • Rising geriatric population
 
Restraints
  • Lack of technological reach
  • Insufficient advanced treatments
 
The report offers a value chain analysis that gives a comprehensive outlook of the market. The attractiveness analysis of this market has also been included so as to evaluate the segments that are anticipated to be profitable during the forecast period.
 
This market has been segmented based on therapeutics such as pancreatic enzyme replacement therapy (PERT) drugs, and sollpura (liprotamase). Pancreatic enzyme replacement therapy is further bifurcated into creon, zenpep, pancreaze, ultresa, viokace, and pertzye. The study incorporates periodic market estimates and forecasts. Each therapeutics has been analyzed based on the market size at regional and country levels.
 
This market has been segmented based on diagnostic tests such as blood tests, endoscopic ultra-sonography (EUS), magnetic resonance imaging (MRI), and CT scanning. The report provides forecast and estimates for each diagnostic tests in terms of market size during the study period. Each diagnostic tests has been further analyzed based on regional and country levels.
 
Geographically, this market has been segmented into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The study details country-level aspects based on each segment and gives estimates in terms of market size.
 
The report also covers the complete competitive landscape of the global Exocrine Pancreatic Insufficiency market with company profiles of key players such as:
  • Abbvie Inc.
  • Allergan plc.
  • Nordmark Arzneimittel GmbH & Co. KG
  • Digestive Care, Inc.
  • Cilian AG
  • Anthera Pharmaceuticals Inc.
  • Janssen Pharmaceuticals Inc.
  • AzurRx BioPharma, Inc.

A detailed description of each has been included, with information in terms of headquarters, inception, stock listing, upcoming capacities, key mergers & acquisitions, financial overview, and recent developments. This analysis gives a thorough idea about the competitive positioning of market players. The report also gives information of the market’s mergers/acquisitions, partnerships, collaborations, new product launches, new product developments and other industry developments.

SEGMENTATIONS IN REPORT:
By Therapeutics:
  • Pancreatic Enzyme Replacement Therapy (PERT) Drugs
    • Creon
    • Zenpep
    • Pancreaze
    • Ultresa
    • Viokace
    • Pertzye
  • Sollpura (Liprotamase)
 
By Diagnostic Tests:
  • Blood Tests
  • Endoscopic Ultra-Sonography (EUS)
  • Magnetic Resonance Imaging (MRI)
  • CT Scanning
 
By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East And Africa

The Global Exocrine Pancreatic Insufficiency Market has been exhibited in detail in the following chapters -
Chapter 1 Exocrine Pancreatic Insufficiency Market Preface 
Chapter 2 Executive Summary
Chapter 3 Exocrine Pancreatic Insufficiency Industry Analysis
Chapter 4 Exocrine Pancreatic Insufficiency Market Value Chain Analysis
Chapter 5 Exocrine Pancreatic Insufficiency Market Analysis By Therapeutics
Chapter 6 Exocrine Pancreatic Insufficiency Market Analysis By Diagnostic Tests
Chapter 7 Exocrine Pancreatic Insufficiency Market Analysis By Geography
Chapter 8 Competitive Landscape Of Exocrine Pancreatic Insufficiency Companies
Chapter 9 Company Profiles Of Exocrine Pancreatic Insufficiency Industry

METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

  • DecisionDatabases.com also provides specific research reports as per Client requirement.
  • Based on the feasibility, data can be provided for custom segmentation
 
DELIVERABLE OPTIONS:
 
DecisionDatabases.com also provides Mini Report and Sections of Reports, in case Client does not want to buy the full report: 
  • Market Data Sheet with all Tables and Graphs
  • Mini Report
  • Market Analysis
    • Drivers
    • Restraints
    • SWOT Analysis
    • Patent Analysis
  • Application Analysis
  • Product Analysis
  • Geography Analysis
  • Company Analysis
  • Competitive Landscape
  • Location of Plants
  • Company Profiles

TABLE OF CONTENTS
 
1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Exocrine Pancreatic Insufficiency Market
       2.2. Global Exocrine Pancreatic Insufficiency Market Snapshot
 
3 . EXOCRINE PANCREATIC INSUFFICIENCY – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Exocrine Pancreatic Insufficiency Market
       3.3. Market Restraints of Exocrine Pancreatic Insufficiency Market
       3.4. Opportunities of Exocrine Pancreatic Insufficiency Market
       3.5. Trends of Exocrine Pancreatic Insufficiency Market
       3.6. Porter’s Five Force Analysis of Exocrine Pancreatic Insufficiency Market
       3.7. Exocrine Pancreatic Insufficiency Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Therapeutics
           3.7.2 Market Attractive Analysis by Diagnostic Tests
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Exocrine Pancreatic Insufficiency Value Chain Analysis
       4.2. Exocrine Pancreatic Insufficiency Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Exocrine Pancreatic Insufficiency Raw Material Manufactures List
           4.2.3. Price Trend of Exocrine Pancreatic Insufficiency Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL EXOCRINE PANCREATIC INSUFFICIENCY MARKET ANALYSIS BY THERAPEUTICS
       5.1 Overview by Therapeutics
       5.2 Global Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics
       5.3 Market Analysis of Pancreatic Enzyme Replacement Therapy (PERT) Drugs by Regions
       5.4 Market Analysis of Creon by Regions
       5.5 Market Analysis of Zenpep by Regions
       5.6 Market Analysis of Pancreaze by Regions
       5.7 Market Analysis of Ultresa by Regions
       5.8 Market Analysis of Viokace by Regions
       5.9 Market Analysis of Pertzye by Regions
       5.10. Market Analysis of Sollpura (Liprotamase) by Regions
 
6 . GLOBAL EXOCRINE PANCREATIC INSUFFICIENCY MARKET ANALYSIS BY DIAGNOSTIC TESTS
       6.1 Overview by Diagnostic Tests
       6.2 Global Exocrine Pancreatic Insufficiency Market Analysis by Diagnostic Tests
       6.3 Market Analysis of Blood Tests by Regions
       6.4 Market Analysis of Endoscopic Ultra-Sonography (EUS) by Regions
       6.5 Market Analysis of Magnetic Resonance Imaging (MRI) by Regions
       6.6 Market Analysis of CT Scanning by Regions
 
7 . GLOBAL EXOCRINE PANCREATIC INSUFFICIENCY MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Exocrine Pancreatic Insufficiency Market Estimate by Market Segment
           7.3.3. North America Exocrine Pancreatic Insufficiency Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Exocrine Pancreatic Insufficiency Market Estimate by Market Segment
           7.4.3. Europe Exocrine Pancreatic Insufficiency Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Exocrine Pancreatic Insufficiency Market Estimate by Market Segment
           7.5.3. Asia Pacific Exocrine Pancreatic Insufficiency Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Exocrine Pancreatic Insufficiency Market Estimate by Market Segment
           7.6.3. Latin America Exocrine Pancreatic Insufficiency Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Exocrine Pancreatic Insufficiency Market Estimate by Market Segment
           7.7.3. Middle East & Africa Exocrine Pancreatic Insufficiency Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa
 
8 . COMPETITIVE LANDSCAPE OF THE EXOCRINE PANCREATIC INSUFFICIENCY COMPANIES
       8.1. Exocrine Pancreatic Insufficiency Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF EXOCRINE PANCREATIC INSUFFICIENCY INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Abbvie Inc.
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Allergan plc.
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. Nordmark Arzneimittel GmbH & Co. KG
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Digestive Care, Inc.
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Cilian AG
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. Anthera Pharmaceuticals Inc.
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Janssen Pharmaceuticals Inc.
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. AzurRx BioPharma, Inc.
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Exocrine Pancreatic Insufficiency Market Snapshot
  • Drivers of The Global Exocrine Pancreatic Insufficiency Market Impact Analysis
  • Restraints of The Global Exocrine Pancreatic Insufficiency Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Pancreatic Enzyme Replacement Therapy (PERT) Drugs by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Creon by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Zenpep by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Pancreaze by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Ultresa by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Viokace by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Pertzye by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Sollpura (Liprotamase) by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis by Diagnostic Tests (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Blood Tests by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Endoscopic Ultra-Sonography (EUS) by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Magnetic Resonance Imaging (MRI) by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in CT Scanning by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market by Geography (USD MN)
  • North America Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • North America Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • North America Exocrine Pancreatic Insufficiency Market Estimate by Country (USD MN)
  • United State Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • United State Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • Rest of North America Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • Rest of North America Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • Europe Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • Europe Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • United Kingdom Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • United Kingdom Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • France Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • France Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • Germany Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • Germany Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • Rest of Europe Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • Rest of Europe Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • Asia Pacific Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • Asia Pacific Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • Asia Pacific Exocrine Pancreatic Insufficiency Market Estimate by Country (USD MN)
  • China Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • China Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • Japan Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • Japan Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • India Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • India Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • Rest of Asia Pacific Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • Rest of Asia Pacific Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • Latin America Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • Latin America Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • Latin America Exocrine Pancreatic Insufficiency Market Estimate by Country (USD MN)
  • Brazil Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • Brazil Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • Rest of Latin America Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • Rest of Latin America Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • Middle East & Africa Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • Middle East & Africa Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • Middle East & Africa Exocrine Pancreatic Insufficiency Market Estimate by Country (USD MN)
  • Middle East Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • Middle East Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • Africa Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • Africa Exocrine Pancreatic Insufficiency Market Estimate by Diagnostic Tests (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
  • Research Scope of Exocrine Pancreatic Insufficiency Report
  • Market Research Process
  • Market Research Methodology
  • Global Exocrine Pancreatic Insufficiency Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Therapeutics
  • Market Attractiveness Analysis by Diagnostic Tests
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Pancreatic Enzyme Replacement Therapy (PERT) Drugs by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Creon by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Zenpep by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Pancreaze by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Ultresa by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Viokace by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Pertzye by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Sollpura (Liprotamase) by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis by Diagnostic Tests (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Blood Tests by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Endoscopic Ultra-Sonography (EUS) by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in Magnetic Resonance Imaging (MRI) by Geography (USD MN)
  • Global Exocrine Pancreatic Insufficiency Market Analysis in CT Scanning by Geography (USD MN)
  • Latin America Exocrine Pancreatic Insufficiency Market by Revenue
  • Middle East & Africa Exocrine Pancreatic Insufficiency Market by Revenue
  • Recent Development in Exocrine Pancreatic Insufficiency Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts  read more..


Global Risperidone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks  read more..


Global Caffeine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on  read more..


Global Rabies Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Radiopharmaceuticals Market Insights, Forecast to 2025

Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and  read more..


Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also  read more..